APA (7th ed.) Citation

Horum, P., Seipel, K., Shaforostova, I., Bertschinger, M., Bacher, U., & Pabst, T. (2026). Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation. Cancers, 18(6), 963. https://doi.org/10.3390/cancers18060963

Chicago Style (17th ed.) Citation

Horum, Pinar, Katja Seipel, Inna Shaforostova, Martina Bertschinger, Ulrike Bacher, and Thomas Pabst. "Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation." Cancers 18, no. 6 (2026): 963. https://doi.org/10.3390/cancers18060963.

MLA (9th ed.) Citation

Horum, Pinar, et al. "Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation." Cancers, vol. 18, no. 6, 2026, p. 963, https://doi.org/10.3390/cancers18060963.